Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-03-02

Clinical Trial Update: "Ready-to-use" Intra-articular Formulation of Mesenchymal Stromal Cells [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for a ready-to-use intra-articular mesenchymal stromal cell formulation in osteoarthritis of the knee.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mesenchymal stromal cell formulation (ready-to-use intra-articular) (mesenchymal stromal cells)

Snippet

Sponsor: Universidad de los Andes, Chile | Conditions: Osteo Arthritis Knee | Phase 2 | Status: UNKNOWN